Ascendis Pharma A/S Ordinary Share (ASND)
- Headquarters
- United States
- Employees
- 1,189
- Market Cap
- $16.5B
About Ascendis Pharma A/S Ordinary Share
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
SentiSense also tracks daily options readings for Ascendis Pharma A/S Ordinary Share: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Ascendis Pharma A/S Ordinary Share stock analysis, sentiment tracking, and market intelligence on SentiSense.